Compare CDMOs with dermatology drug manufacturing expertise for topical formulations, transdermal systems, and injectable biologics for skin conditions. Filter by dosage form, scale, and certifications.
50 companies listed
Dermatology drug manufacturing is dominated by topical formulations -- creams, ointments, gels, lotions, foams, and solutions. These semi-solid dosage forms require specialized mixing equipment (high-shear mixers, homogenizers), precise temperature control during formulation, and validated filling lines for tubes, jars, pumps, and airless dispensers. The manufacturing expertise is distinct from solid dose or injectable production.
Skin penetration is the formulation challenge. The stratum corneum (outermost skin layer) is an effective barrier that most drugs cannot cross easily. CDMOs need formulation scientists experienced with penetration enhancers, nano-emulsions, liposomal delivery, and permeation testing (Franz diffusion cells). The choice of vehicle (cream vs ointment vs gel) significantly affects drug delivery and patient acceptance.
Biologics are entering dermatology. Monoclonal antibodies for psoriasis (anti-IL-17, anti-IL-23), atopic dermatitis (anti-IL-4R, anti-IL-13), and other inflammatory skin conditions have transformed treatment. While these are manufactured as standard injectable biologics, the combination with topical products in treatment protocols means some CDMOs serve both modalities for dermatology sponsors.
India
Envee Drugs Pvt. Ltd. is an Indian API manufacturer located in Gujarat, India, producing small molecule active pharmaceutical ingredients including hydrocortisone, clobetasol propionate, and other steroid and dermatological APIs. The company supplies APIs to pharmaceutical companies globally.
Italy
Steroid S.p.A. is one of the oldest privately-owned steroid API manufacturing companies, founded in the early 1950s in Italy. The company specializes in the synthesis of steroid esters including corticosteroids, progestinics, hormones, anabolics, and estrogens for both human and veterinary use, with over 15 tons installed capacity.
India
Symbiotec Pharmalab is a leading Indian manufacturer of corticosteroid and steroidal-hormone APIs with a global leadership position. With over 30 years of experience, the company has evolved from lab-scale manufacturing to industrial-scale production, operating two FDA-approved facilities (Rau and Pithampur, Indore). The company offers integrated CDMO solutions across organic chemistry, biotechnology/fermentation, and complex injectable platforms. It holds a 50%+ global market share in key steroid API molecules and serves 200+ customers in 40+ countries.
India
Indian WHO-GMP certified manufacturer and exporter of pharmaceutical active pharmaceutical ingredients (APIs) for human and veterinary use, plus pharmaceutical intermediates and phase transfer catalysts. Not a contract manufacturer -- produces and sells own API portfolio. Headquartered in Mumbai with manufacturing plant in Ankleshwar, Gujarat. Facility covers 5,000 sqm with dedicated clean rooms for human and veterinary APIs.
India
Synergene Active Ingredients is a fast-growing Indian API manufacturer incorporated in 2006, with 40 years of industrial experience and 800+ employees. The company manufactures 30+ APIs serving 300+ customers in 50+ countries. Synergene operates four manufacturing units in Hyderabad and Visakhapatnam with combined production capacity of 800+ KL (plus 700 KL under installation). The company has CEPs from EDQM, US DMFs, Japanese DMFs, ANVISA CBPF, and WHO GMP certifications. Synergene also produces specialty chemicals for skincare, sun care, and haircare applications.
Taiwan
Syn-Tech Chem & Pharm Co. Ltd is a Taiwanese API manufacturer established over 30 years ago, providing good quality APIs to customers worldwide including USA, Japan, Korea, and Europe. The company has passed multiple regulatory audits and holds PMDA, US FDA, KFDA, and TFDA approvals. Syn-Tech is expanding its CDMO capabilities and manufactures APIs such as guanfacine HCl and crotamiton. The company won the 2003 National Biotechnology and Medical Quality Award in Taiwan.
France
Canada
JAMP Pharma Group is a leading Canadian pharmaceutical company with over 35 years in the industry, active across generic drugs (JAMP Pharma), biosimilars (BioJAMP), branded products (Orimed Pharma), natural health products (Wampole/Laboratoire Suisse), and beauty products (Cosmetic Import). The company acquired a pharmaceutical manufacturing facility in Levis, Quebec, and manufactures prescription drugs in Canada through its JAMP Pharma Manufacturing division.
France
Pierre Fabre CDMO is the contract development and manufacturing arm of the Pierre Fabre Group, a French pharmaceutical and dermo-cosmetics company. Offers over 20 years of CDMO services across pharma and non-pharma active ingredients, dry forms, non-sterile liquids, and biologics including monoclonal antibodies and ADCs. Operates R&D site in Toulouse and 3+ industrial sites in France. Expertise spans extraction, chromatographic purification, chemical synthesis, cytotoxic compound production, plant cell culture, and supercritical CO2 technology. Manufactures 2,100 metric tons of plant extracts and 100+ active ingredients annually.
Switzerland
Acino International AG is a Swiss pharmaceutical company headquartered in Zurich, operating as a CDMO specializing in oral solid dosage forms. With over 50 years of manufacturing experience, they operate facilities in five countries with annual capacity of billions of tablets and millions of capsules. They specialize in advanced drug delivery systems including multi-unit pellet systems (MUPS), minitablets, and complex modified-release formulations.
Spain
Reig Jofre (Laboratorio Reig Jofre, S.A.) is a Spanish pharmaceutical company founded in 1929 that operates both as a pharmaceutical company with its own products and as a CDMO. They have four development and production centres in Europe (two in Toledo, one in Barcelona, one in Sweden) with over 1,100 employees. Their CDMO capabilities include sterile lyophilizates, sterile liquids, non-sterile liquids, and beta-lactam manufacturing. Known for excellence in freeze-drying technology and advanced sterile manufacturing. FDA-registered with manufacturing and analysis operations, though regulatory history shows 3 OAI inspections.
United States
Sofgen Pharmaceuticals, part of Procaps Group, is an integrated softgel CDMO that offers end-to-end solutions in softgel technologies from development through delivery. The company serves pharmaceutical, OTC, and nutraceutical customers, with operations across 13 countries in the Americas and customers in 50+ countries.
Japan
Division of Terumo Corporation (TSE:4543), a global healthcare technology leader since 1921 with 30,000+ employees. Provides sterile injectable contract development and manufacturing (CDMO) services from combination device design and formulation development to commercial manufacturing. Offers a portfolio of injection, infusion, and primary packaging solutions including PLAJEX polymer pre-fillable syringes, Immucise intradermal injection systems, hypodermic needles, and Surflo winged infusion sets. Recently expanded CDMO services outside Japan for global market and is doubling capacity.
Italy
Trifarma S.p.A. is an international and independent Italian group dedicated to developing, manufacturing, and supplying high-quality Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry. The company has R&D laboratories for synthetic organic chemistry process development at lab and pilot scale, with rapid lab-to-industrial scale development. API portfolio covers cardiovascular, anti-infective, nervous system, dermatological/ophthalmic, steroids, and musculoskeletal categories.
India
Unilab Chemicals & Pharmaceuticals Pvt Ltd is an Indian manufacturer of Active Pharmaceutical Ingredients (APIs), bulk drugs, and finished dosage forms, established in 1978 near Mumbai. Their product portfolio focuses heavily on antiseptic and disinfectant APIs and formulations including Chlorhexidine Gluconate, Povidone Iodine, Cetrimide, Benzalkonium Chloride, and related topical/liquid formulations. They also manufacture APIs like Guaifenesin, Phenothiazine, and other pharmaceutical chemicals.
Greece
UNI-PHARMA S.A. is a major Greek pharmaceutical company (part of the Tsetis Group) with over 60 years of operations. It researches, develops, produces, and distributes pharmaceutical products, food supplements, and medical devices. It holds the first place in sales (units) among purely Greek companies in the Greek pharmaceutical market. The company offers contract manufacturing services (listed as CMO/CDMO on PharmaSource) while also marketing its own extensive portfolio of generic medicines across multiple therapeutic categories. Their product range includes a very wide array of small-molecule generics.
India
Innova Captab Ltd is the second largest domestic formulations CDMO in India, providing contract development and manufacturing services across tablets, capsules, dry syrups, ointments, liquid orals, and dry powder injections. The company operates five state-of-the-art facilities with nine independent manufacturing blocks in Baddi, Dehradun, Taloja, and Kathua, serving 14 of the top 15 Indian pharmaceutical companies.
United States
US-based topical and transdermal pharmaceutical CDMO, now merged with MedPharm (Durham, NC). Provides end-to-end services from formulation development through commercial manufacturing for topical, transmucosal, and transdermal drug products. Specializes in semi-solids, aerosols, liquids, injections, and transdermal patches. Offers in-vitro permeation testing (IVPT), in-vitro release testing (IVRT), disease activity models, tissue protein binding, and continuous flow technologies. GMP-certified manufacturing for generics, OTC, and prescription products.
India
Maharshi Pharma Chem Pvt Ltd is an Indian API manufacturer specializing in corticosteroid APIs since 2014. The company manufactures APIs to cGMP standards with expertise in developing corticosteroids for pharmaceutical companies producing topical, inhaled, and injectable formulations. Products include Betamethasone, Dutasteride, and other corticosteroid intermediates. The company operates from Ahmedabad, India.
Thailand
Biolab Company Limited is a leading Thai pharmaceutical manufacturer with 45+ years of experience, producing pharmaceuticals, dietary supplements, and cosmeceuticals. The company operates a 24,000 sqm factory in Samut Prakan, Thailand with OEM/ODM contract manufacturing capabilities. Certified PIC/S GMP (Singapore HSA), EU GMP, ISO/IEC 17025, Halal, and Thai FDA Quality Award. Exports to 20+ countries.
India
West Bengal Chemical Industries Limited (WBCIL) is a GMP and ISO certified API manufacturer based in Kolkata, India, with over 60 years of experience. The company specializes in producing active pharmaceutical ingredients including injectable iron APIs, chelated minerals, and liposomal technology products. WBCIL holds multiple FDA registrations across four FEI numbers.
South Korea
Caregen Co., Ltd. is a South Korean biotechnology company and global leader in biomimetic peptide synthesis. The company manufactures peptide-based APIs and health/cosmetic ingredients, with FDA inspection history and drug pipeline activities in dermatology and ophthalmology applications.
India
Morepen Laboratories Limited is an Indian pharmaceutical company with 40+ years of expertise in API and formulation manufacturing. The company has recently secured an INR 825 crore (approx. USD 100M) multi-year global CDMO mandate, marking a significant expansion into contract manufacturing. Morepen operates a scientifically integrated complex in Baddi with 10 dedicated manufacturing plants. The company exports to 80+ countries and holds FDA, WHO GMP, and EU GMP certifications. Known for the consumer brand Dr. Morepen (home health devices).
Canada
Pharmascience is Canada's largest privately-owned pharmaceutical company, a leading manufacturer of generic, branded, and over-the-counter pharmaceuticals. The company has recently expanded its CDMO services with a new commercial business unit, investing over $120 million to expand its sterile injectable manufacturing facility in Candiac, Quebec, aiming to more than triple capacity. Pharmascience's ambition is to become a world leader in the sterile injectable CDMO segment. The company distributes products in over 50 countries and invests approximately $65 million per year in R&D in Canada. The Pendopharm division offers specialty medicines in gastroenterology, orthopedics, and neurology.
Belgium
Pfizer CentreOne is a global CDMO embedded within Pfizer, specializing in commercial manufacturing of oral solid doses, sterile injectables, biologics including monoclonal antibodies, and antibody-drug conjugates. It leverages Pfizer's global manufacturing network across six continents with cGMP-compliant sites and over 170 years of pharmaceutical manufacturing expertise, backed by $1B+ annual manufacturing investments.
Spain
Grupo Ferrer Internacional (Ferrer) is a Spanish pharmaceutical company with certified production plants in Spain and the United States that manufactures chemical substances, APIs, and finished pharmaceutical products both for its own portfolio and for third parties under contract. The company's FDA registration is for API manufacture and analysis, and its website explicitly states it manufactures for third parties.
Belgium
Conforma NV is a GMP and ISO 13485 certified Belgian pharmaceutical and medical device company specializing in the production and packaging of semi-solid and liquid dosage forms. With over 65 years of experience, the company provides contract manufacturing, bulk manufacturing, packaging, and quality control services for creams, gels, pastes, ointments, herbal liquid extracts, and tinctures. Based in Destelbergen, Belgium, Conforma serves pharmaceutical and medical device customers.
Czechia
Contipro a.s. is a Czech biotechnology company and one of the world's leading producers of hyaluronic acid for pharmaceutical and cosmetic industries. Founded in 1990, the company specializes in biotechnological production of ultra-pure sodium hyaluronate using bacterial fermentation of Streptococcus zooepidemicus. Contipro manufactures APIs, hyaluronan-based medical devices, veterinary products, and anti-aging cosmetic ingredients, with FDA and Czech State Institute for Drug Control (SIDC) certifications.
India
Indian pharmaceutical CDMO specializing in pre-finished formulation intermediates (PFI) and finished dosage forms (FDF). Manufactures oral solids, oral liquids, injectables, ophthalmics, topicals, and inhalation products. Strong focus on pellet technology and nanotechnology-based drug delivery systems. CRAMS (Contract Research and Manufacturing Services) provider.
India
Duplicate entry for Murli Krishna Pharma Private Ltd. (mkppl.com) - same company, same website domain. Indian pharmaceutical CDMO specializing in PFI and FDF products with CRAMS services.
Italy
AbbVie Contract Manufacturing is an embedded CMO within AbbVie, providing third-party contract manufacturing services for over 40 years across 12 locations in the US and Europe. They offer services spanning antibody drug conjugates, aseptic fill/finish, biologics (mAbs and derivatives), custom API, eye care, hot melt extrusion, HPAPI, and oral solid dose manufacturing.
Spain
Cyndea Pharma S.L. is a Spanish CMO dedicated to the development and manufacture of generic pharmaceutical products of steroidal origin, women's health therapies, and oncology treatments in tablet and soft gelatin capsule forms. Part of the Cinfa group, the facility occupies 10,236 m2 and employs 276 professionals. The company is FDA-registered and handles specialized formulations including hormonal products.
Italy
Abiogen Pharma S.p.A. is an Italian pharmaceutical company established in 1997 with a century-long heritage, performing CMO and CDMO activities alongside its own product portfolio. They offer formulation development, analytical testing, scale-up, and commercial production from their cutting-edge manufacturing plant in Pisa. They specialize in bone metabolism, hypovitaminosis D, pain, dermatology, respiratory, and gastroenterology.
Brazil
Nortec Quimica is the largest Active Pharmaceutical Ingredient (API) manufacturer in Latin America, operating since 1985 in Duque de Caxias, Brazil. The company produces over 50 APIs, with strong expertise in local anesthetics (lidocaine, bupivacaine, prilocaine, articaine, mepivacaine), as well as escetamine and olanzapine. Nortec offers a complete CDMO platform from R&D through commercial-scale API production.
Canada
ACIC Pharmaceuticals Inc is a CDMO headquartered in Coral Springs, Florida, providing integrated pharmaceutical solutions from molecule to market. They offer API manufacturing, CDMO services for complex injectables including long-acting and cytotoxic injectables, regulatory support, and pharmaceutical equipment solutions. They have 249 FDA-approved products across a wide range of dosage forms.
Poland
Adamed Pharma S.A. is a European pharmaceutical and biotechnology company headquartered in Poland, established in 1986. They manufacture approximately 94 million units of medicine packs annually across 19 therapeutic areas, with products available in dozens of markets. They hold GMP and GDP API certifications, and operate as both a manufacturer of their own products and a licensee, with 256 pharmaceutical patents and approximately 900 SKUs.
India
Addii Biotech Pvt Ltd is an Indian pharmaceutical company established in 2010, initially as a marketing company that expanded into manufacturing in 2017. They manufacture tablets, capsules, ointments, dry syrups, and other preparations at their WHO-GMP certified facility in Baddi, Himachal Pradesh. They hold ISO 9001:2015, WHO-GMP, and FDA-Ghana certifications and supply to government institutions and hospitals.
Greece
Adelco S.A. is one of the oldest pharmaceutical and cosmetics manufacturers in Greece, established in 1934. They operate as both a CMO/CDMO and a branded pharmaceutical and cosmetics manufacturer. Their EU-GMP certified production facility manufactures a range of pharmaceutical products including tablets, capsules, liquids, creams, and ointments. They are an independent manufacturer extending activities beyond Greek national borders.
China
Minsheng Group Shaoxing Pharmaceutical Co., Ltd. is a Chinese API manufacturer established in 2002, subsidiary of Hangzhou Minsheng Pharmaceutical Holding Group. The company specializes in R&D and production of high-quality APIs for human and veterinary use, as well as intermediates and cell culture products. Over 50% of products are exported to Europe, the US, Japan and other developed countries. FDA-registered for API manufacture with 8 FDA inspections (3 NAI, 5 VAI).
Germany
5N Plus is a global manufacturer of high-purity metals and specialty semiconductors. Their Lubeck, Germany facility manufactures GMP-certified bismuth-based active pharmaceutical ingredients used in over-the-counter antacids and antibiotic creams, including bismuth subsalicylate, bismuth subcitrate, and bismuth subgallate. They also serve semiconductor, solar, and electronics markets.
India
Aizant Drug Research Solutions Pvt. Ltd., founded in 2008, is a trusted global CDMO offering comprehensive API and Formulation R&D, CDMO, CMO, and CRO services across multiple therapeutic areas and dosage forms. The company operates USFDA and EU-accredited facilities with capabilities in hot melt extrusion, spray drying, and complex generics, providing end-to-end pharmaceutical development and manufacturing solutions.
India
Akums Drugs & Pharmaceuticals Ltd. is India's largest CDMO with 30% domestic market share, operating 15+ state-of-the-art manufacturing facilities with over 4,100 commercialized formulations across 60+ dosage forms. The company serves 1,500+ pharmaceutical companies and provides end-to-end services including API manufacturing (737 MT annual capacity across 3 facilities), formulation development, clinical trial materials, and commercial-scale production of tablets, capsules, injectables, soft gels, syrups, topicals, and nutraceuticals.
Italy
Altergon Italia is an Italian CDMO specializing in medicated hydrogel patches (transdermal drug delivery), drug-in-adhesive patches, and biotechnological production of ultra-pure hyaluronic acid. The company also provides secondary packaging, pharmaceutical warehousing, medical device production, and QC analysis with QP release certifications. They hold CEP certification and an FDA Master File for sodium hyaluronate.
United States
Padagis LLC is a U.S.-based generic pharmaceutical company specializing in development and manufacturing of extended topical and specialty pharmaceutical products. Product portfolio includes prescription creams, ointments, gels, foams, sprays, patches, nasal treatments, and suppositories, with a focus on Paragraph IV generic products. Also manufactures naloxone nasal spray (awarded New York State Department of Health contract in 2025). Over 1,300 employees. Offers contract manufacturing, licensing, and joint venture partnerships.
Japan
API Co., Ltd. is a Japanese pharmaceutical company specializing in contract manufacturing (CMO/CDMO) of antibiotics (vials, lyophilized products), APIs (including heparinoid), and biotech products. Their Ikeda Pharmaceutical Plant handles antibiotic formulation, lyophilization, powder filling, and packaging under GMP conditions.
India
Zydus Lifesciences Ltd. (formerly Cadila Healthcare) is a major Indian pharmaceutical company headquartered in Ahmedabad, Gujarat, ranked 4th in the Indian pharma industry with 29,000+ employees globally. In June 2025, Zydus entered the global biologics CDMO business by acquiring Agenus Inc.'s U.S. manufacturing facilities in Emeryville and Berkeley, California for $75M upfront (plus $50M milestones), now operating as independent subsidiary Zylidac Bio LLC. These facilities provide end-to-end biologics development and manufacturing from pre-clinical to commercial stages, including monoclonal antibody manufacturing for Phase-3 immuno-oncology products (Botensilimab and Balstilimab). Zydus has 15 FDA-registered facilities, 156 FDA-approved products across capsules, tablets, creams, gels, injectables (including liposomal), ointments, suppositories, and transdermal patches. They have 58 FDA inspections (25 NAI, 28 VAI, 5 OAI) and 51 recalls (2 Class I, 40 Class II, 9 Class III). Manufacturing sites span Gujarat, Maharashtra, Goa, Himachal Pradesh, Sikkim (India), plus US (Vermont, Pennsylvania, Missouri) and Brazil. Their CDMO services are specifically the biologics arm through Zylidac Bio -- the broader Zydus business is primarily own-brand generic pharmaceuticals.
Argentina
Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company focused on branded and generic formulations, with an API manufacturing arm called Glenmark Life Sciences. The company manufactures APIs and finished dosage forms primarily for its own portfolio, spanning dermatology, respiratory, oncology, and cardiovascular therapeutic areas. Glenmark Life Sciences produces over 120 APIs across multiple manufacturing sites in India.
India
BioMatrix Healthcare Pvt. Ltd. is an Indian pharmaceutical company established in 2007, headquartered in Ahmedabad, specializing in 100% export of pharmaceutical products to 40+ countries. Their manufacturing facility is WHO-GMP, EU-GMP certified and compliant with US-FDA, UK-MHRA, and ANVISA standards, with Health Canada site approval. Capacity: 5 billion tablets, 1 billion capsules, 24 million liquids, and 18 million dry syrups per annum. 1,000+ product registrations. Expanding with a new API manufacturing facility in Vadodara.
Portugal
Laboratorio Edol, S.A. is a Portuguese pharmaceutical company specializing in development, manufacturing, and marketing of medicines, medical devices, cosmetics, and food supplements, with a focus on Ophthalmology, Dermatology, Otorhinolaryngology, and Dermocosmetics. They operate from their factory in Linda-a-Velha, Portugal and offer contract manufacturing (producao para terceiros) services across a wide range of pharmaceutical forms including small and large volume injectables, gels, creams, ointments, syrups, oral solutions and suspensions, cutaneous solutions, and enemas. They have two industrial units equipped for third-party manufacturing.
Bahrain
Gulf Biotech is a pharmaceutical company based in Bahrain that manufactures injectable formulation products and offers contract manufacturing services for sterile formulations. The company provides lyophilized vials, cartridges, ampoules, pre-filled syringes, and sterile emulsion technology from its state-of-the-art manufacturing facility.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.